Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Decline; Fiscal 2025 Outlook Trimmed

MT Newswires Live10-30

Takeda Pharmaceutical (TAK) reported fiscal Q2 core earnings Thursday of 128 Japanese yen ($0.83) per share, down from 134 yen a year earlier.

Two analysts polled by FactSet expected 66.98 yen.

Revenue for the quarter ended Sept. 30 was 1.113 trillion yen, compared with 1.176 trillion yen a year earlier.

Analysts polled by FactSet expected 1.197 trillion yen

The company said it now expects fiscal 2025 core earnings of 479 yen per share, from 485 yen previously. Analysts polled by FactSet expect 246.9 yen.

Takeda also lowered its fiscal 2025 revenue guidance to 4.5 trillion yen, from 4.53 trillion yen previously. Analysts polled by FactSet expect 4.582 trillion yen.

Shares of Takeda Pharmaceutical were down nearly 2% in recent premarket activity Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2579111892?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 17:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579111892","market":"sh","top_or_hot":-1,"title":"Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Decline; Fiscal 2025 Outlook Trimmed","media":"MT Newswires Live","content":"<html><body><p> Takeda Pharmaceutical (TAK) reported fiscal Q2 core earnings Thursday of 128 Japanese yen ($0.83) per share, down from 134 yen a year earlier.</p><p>Two analysts polled by FactSet expected 66.98 yen.</p><p>Revenue for the quarter ended Sept. 30 was 1.113 trillion yen, compared with 1.176 trillion yen a year earlier.</p><p>Analysts polled by FactSet expected 1.197 trillion yen</p><p>The company said it now expects fiscal 2025 core earnings of 479 yen per share, from 485 yen previously. Analysts polled by FactSet expect 246.9 yen.</p><p>Takeda also lowered its fiscal 2025 revenue guidance to 4.5 trillion yen, from 4.53 trillion yen previously. Analysts polled by FactSet expect 4.582 trillion yen.</p><p>Shares of Takeda Pharmaceutical were down nearly 2% in recent premarket activity Thursday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Takeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Decline; Fiscal 2025 Outlook Trimmed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTakeda Pharmaceutical's Fiscal Q2 Core Earnings, Revenue Decline; Fiscal 2025 Outlook Trimmed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-10-30 17:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Takeda Pharmaceutical (TAK) reported fiscal Q2 core earnings Thursday of 128 Japanese yen ($0.83) per share, down from 134 yen a year earlier.</p><p>Two analysts polled by FactSet expected 66.98 yen.</p><p>Revenue for the quarter ended Sept. 30 was 1.113 trillion yen, compared with 1.176 trillion yen a year earlier.</p><p>Analysts polled by FactSet expected 1.197 trillion yen</p><p>The company said it now expects fiscal 2025 core earnings of 479 yen per share, from 485 yen previously. Analysts polled by FactSet expect 246.9 yen.</p><p>Takeda also lowered its fiscal 2025 revenue guidance to 4.5 trillion yen, from 4.53 trillion yen previously. Analysts polled by FactSet expect 4.582 trillion yen.</p><p>Shares of Takeda Pharmaceutical were down nearly 2% in recent premarket activity Thursday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TAK","symbol_name":"武田制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2579111892","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579111892","pubTimestamp":1761816763,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Takeda Pharmaceutical  reported fiscal Q2 core earnings Thursday of 128 Japanese yen  per share, down from 134 yen a year earlier.Two analysts polled by FactSet expected 66.98 yen.Revenue for the quarter ended Sept. 30 was 1.113 trillion yen, compared with 1.176 trillion yen a year earlier.Analysts polled by FactSet expected 1.197 trillion yenThe company said it now expects fiscal 2025 core earnings of 479 yen per share, from 485 yen previously. Analysts polled by FactSet expect 246.9 yen.Takeda also lowered its fiscal 2025 revenue guidance to 4.5 trillion yen, from 4.53 trillion yen previously. Analysts polled by FactSet expect 4.582 trillion yen.Shares of Takeda Pharmaceutical were down nearly 2% in recent premarket activity Thursday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TAK":"武田制药","BK4007":"制药"},"translate_title":"武田制药第二财季核心盈利、营收下降；2025财年前景下调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TAK":1},"content_text":"Takeda Pharmaceutical (TAK) reported fiscal Q2 core earnings Thursday of 128 Japanese yen ($0.83) per share, down from 134 yen a year earlier.Two analysts polled by FactSet expected 66.98 yen.Revenue for the quarter ended Sept. 30 was 1.113 trillion yen, compared with 1.176 trillion yen a year earlier.Analysts polled by FactSet expected 1.197 trillion yenThe company said it now expects fiscal 2025 core earnings of 479 yen per share, from 485 yen previously. Analysts polled by FactSet expect 246.9 yen.Takeda also lowered its fiscal 2025 revenue guidance to 4.5 trillion yen, from 4.53 trillion yen previously. Analysts polled by FactSet expect 4.582 trillion yen.Shares of Takeda Pharmaceutical were down nearly 2% in recent premarket activity Thursday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2579111892","isCrawlerRequest":true}